Biosimilars for Retinal Diseases - Indo-US Symposium
Ophthalmology, especially retinal disease management, might see a big change in the coming few years as more and more biosimilars are approved for the clinical use in both developing and developed world. It remains to be seen how well the drugs will be priced and how the innovator companies will protect their market share...
Read More
Corporate House, Near Sola Bridge, S.G. Highway, Thaltej, Ahmedabad-380054, Gujarat, INDIA.
MEDICAL DISCLAIMER
All content found on the razumab.co.in website, including: text, images, audio, or other formats were created for informational purposes only. Offerings for continuing education credits are clearly identified and the appropriate target audience is identified. The content is not intended or meant to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this Website. If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 102 immediately. razumab.co.in does not recommend or endorse any specific tests, physicians, products, procedures, opinions, or other information that may be mentioned on razumab.co.in. Reliance on any information provided by razumab.co.in, employees, contracted writers, or medical professionals presenting content for publication to razumab.co.in is solely at your own risk. The site may contain health- or medical-related materials or discussions regarding Eye diseases. If you find these materials offensive, you may not want to use our Site. The Site and its Content are provided on an "as is" basis. Links to educational content not created by razumab.co.in are taken or accessed at your own risk. razumab.co.in is not responsible for the claims of external websites and education companies.
Disclaimer: User data will be collected for better functionality and user response and data included in the chatbot will be kept confidential and will not be shared elsewhere.
